Synthesis, spectral analysis and pharmacological study of N’-substituted-2-(5-((2,4-dimethylphenoxy)methyl)-1,3,4-oxadiazol-2-ylthio)acetohydrazides
A series of molecules bearing multiple functional groups were synthesized to study their antibiotic effect against Gram-positive and Gram-negative bacteria and lipoxygenase activity as well. 2,4-Dimethylcarbolic acid (1) was refluxed with ethyl 2-bromoacetate to synthesize ethyl 2-(2,4-dimethylpheno...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculdade de Ciencias Farmaceuticas (Biblioteca)
2016
|
Subjects: |
n' (2 hydroxybenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide
n' (3 hydroxybenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide
n' (4 hydroxybenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide
|
Online Access: | View Fulltext in Publisher View in Scopus |
LEADER | 05210nam a2200781Ia 4500 | ||
---|---|---|---|
001 | 10.1590-s1984-82502016000300013 | ||
008 | 220120s2016 CNT 000 0 und d | ||
020 | |a 19848250 (ISSN) | ||
245 | 1 | 0 | |a Synthesis, spectral analysis and pharmacological study of N’-substituted-2-(5-((2,4-dimethylphenoxy)methyl)-1,3,4-oxadiazol-2-ylthio)acetohydrazides |
260 | 0 | |b Faculdade de Ciencias Farmaceuticas (Biblioteca) |c 2016 | |
520 | 3 | |a A series of molecules bearing multiple functional groups were synthesized to study their antibiotic effect against Gram-positive and Gram-negative bacteria and lipoxygenase activity as well. 2,4-Dimethylcarbolic acid (1) was refluxed with ethyl 2-bromoacetate to synthesize ethyl 2-(2,4-dimethylphenoxy)acetate (2). Compound 2 was converted to the corresponding hydrazide 3, again on refluxing with hydrazine. The compound 5-((2,4-dimethylphenoxy)methyl)-1,3,4-oxadiazol-2-thiol (4) was synthesized by the reaction of 3 and CS2 in the presence of KOH. Compound 4 was further converted to the corresponding ester 5 and then 2-(5-((2,4-dimethylphenoxy)methyl)-1,3,4-oxadiazol-2-ylthio)acetohydrazide (6). The final molecules N’-substituted-2-(5-((2,4-dimethylphenoxy)methyl)-1,3,4-oxadiazol-2-ylthio)acetohydrazide, 8a-m, bearing ether, 1,3,4-oxadiazole, thioether, hydrazone and azomethine functional groups were synthesized by stirring the aryl carboxaldehydes 7a-m with 6 in methanol at room temperature. The depicted structures of all synthesized molecules were corroborated by IR, 1H-NMR and EIMS spectral data analysis. 8m and 8i showed substantial antibacterial activity and lipoxygenase inhibitory activity, respectively. © 2016, Faculdade de Ciencias Farmaceuticas (Biblioteca). All rights reserved. | |
650 | 0 | 4 | |a 1,3,4 oxadiazole derivative |
650 | 0 | 4 | |a 2,4 dimethylcarbolic acid |
650 | 0 | 4 | |a 5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 thiol |
650 | 0 | 4 | |a acetic acid |
650 | 0 | 4 | |a Acetohydrazides/antibacterial activity/acetohydrazides/lipoxygenase/inhibition activity |
650 | 0 | 4 | |a Acetohydrazides/synthesis |
650 | 0 | 4 | |a antibacterial activity |
650 | 0 | 4 | |a Article |
650 | 0 | 4 | |a azomethine ylide |
650 | 0 | 4 | |a Bacillus subtilis |
650 | 0 | 4 | |a baicalein |
650 | 0 | 4 | |a controlled study |
650 | 0 | 4 | |a drug structure |
650 | 0 | 4 | |a drug synthesis |
650 | 0 | 4 | |a enzyme inhibition |
650 | 0 | 4 | |a Escherichia coli |
650 | 0 | 4 | |a ether |
650 | 0 | 4 | |a ethyl 2 (2,4 dimethylphenoxy)acetate |
650 | 0 | 4 | |a ethyl 2 bromoacetate |
650 | 0 | 4 | |a hydrazide |
650 | 0 | 4 | |a hydrazone derivative |
650 | 0 | 4 | |a infrared spectroscopy |
650 | 0 | 4 | |a lipoxygenase |
650 | 0 | 4 | |a mass spectrometry |
650 | 0 | 4 | |a methanol |
650 | 0 | 4 | |a minimum inhibitory concentration |
650 | 0 | 4 | |a n' (2 hydroxybenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide |
650 | 0 | 4 | |a n' (2 methylbenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide |
650 | 0 | 4 | |a n' (2 nitrobenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide |
650 | 0 | 4 | |a n' (3 hydroxybenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide |
650 | 0 | 4 | |a n' (3 methylbenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide |
650 | 0 | 4 | |a n' (3 nitrobenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide |
650 | 0 | 4 | |a n' (4 hydroxybenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide |
650 | 0 | 4 | |a n' (4 methoxybenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide |
650 | 0 | 4 | |a n' (4 methylbenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide |
650 | 0 | 4 | |a n' (4 nitrobenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide |
650 | 0 | 4 | |a n' [4 (diethylamino)benzylidene] 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide |
650 | 0 | 4 | |a n' [4 (dimethylamino)benzylidene] 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide |
650 | 0 | 4 | |a n' 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide derivative |
650 | 0 | 4 | |a n' benzylidene 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide |
650 | 0 | 4 | |a nonhuman |
650 | 0 | 4 | |a phenol |
650 | 0 | 4 | |a proton nuclear magnetic resonance |
650 | 0 | 4 | |a Pseudomonas aeruginosa |
650 | 0 | 4 | |a room temperature |
650 | 0 | 4 | |a Salmonella enterica serovar Typhi |
650 | 0 | 4 | |a Staphylococcus aureus |
650 | 0 | 4 | |a thiol |
650 | 0 | 4 | |a unclassified drug |
700 | 1 | 0 | |a Abbasi, M.A. |e author |
700 | 1 | 0 | |a Aziz-ur-Rehman |e author |
700 | 1 | 0 | |a Rasool, S. |e author |
700 | 1 | 0 | |a Shah, S.A.A. |e author |
700 | 1 | 0 | |a Siddiqui, S.Z. |e author |
773 | |t Brazilian Journal of Pharmaceutical Sciences |x 19848250 (ISSN) |g 52 3, 471-482 | ||
856 | |z View Fulltext in Publisher |u https://doi.org/10.1590/s1984-82502016000300013 | ||
856 | |z View in Scopus |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-85006043172&doi=10.1590%2fs1984-82502016000300013&partnerID=40&md5=601a74d0191422325549fcfb7892de56 |